Human medicines European public assessment report (EPAR): Champix, varenicline, Date of authorisation: 25/09/2006, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 6, Status: Authorised
PRIME eligibility requests: 2026 deadlines for submission and timetable for assessment
Human medicines European public assessment report (EPAR): Spravato, esketamine, Date of authorisation: 18/12/2019, Revision: 16, Status: Authorised
Management Board formally approves renewal of Executive Director’s mandate
Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions
Human medicines European public assessment report (EPAR): Tasmar, tolcapone, Date of authorisation: 27/08/1997, Revision: 26, Status: Authorised
Minutes of the PRAC meeting 7-10 July 2025
PSUSA/00010987/202501